APA (7th ed.) Citation

Harbeck, N., Ciruelos, E., Jerusalem, G., Müller, V., Niikura, N., Viale, G., . . . Marmé, F. (2024). Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: A phase 3b/4 trial. Nature medicine, 30(12), . https://doi.org/10.1038/s41591-024-03261-7

Chicago Style (17th ed.) Citation

Harbeck, Nadia, et al. "Trastuzumab Deruxtecan in HER2-positive Advanced Breast Cancer with or Without Brain Metastases: A Phase 3b/4 Trial." Nature Medicine 30, no. 12 (2024). https://doi.org/10.1038/s41591-024-03261-7.

MLA (9th ed.) Citation

Harbeck, Nadia, et al. "Trastuzumab Deruxtecan in HER2-positive Advanced Breast Cancer with or Without Brain Metastases: A Phase 3b/4 Trial." Nature Medicine, vol. 30, no. 12, 2024, https://doi.org/10.1038/s41591-024-03261-7.